{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:16:44Z","timestamp":1788869804053,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12350-014-9898-0","type":"journal-article","created":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T11:31:09Z","timestamp":1401449469000},"page":"862-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Asystole following regadenoson infusion in stable outpatients"],"prefix":"10.1016","volume":"21","author":[{"given":"Jeffrey","family":"Rosenblatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-014-9898-0_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-014-9898-0_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcmg.2008.02.003","article-title":"Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results","volume":"1","author":"Cerqueira","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-014-9898-0_bib3","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s12350-012-9610-1","article-title":"Complete heart block associated with regadenoson: A real side effect","volume":"19","author":"Pandit","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-014-9898-0_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12350-011-9373-0","article-title":"Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine","volume":"18","author":"Grady","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-014-9898-0_bib5","unstructured":"U.S. Food and Drug Administration. Drug Safety Communications: FDA warns of rare but serious risk of heart attack and death with cardiac nuclear stress test drugs Lexiscan (regadenoson) and Adenoscan (adenosine). http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM375668. Accessed February 13, 2014."},{"key":"10.1007\/s12350-014-9898-0_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/phar.1238","article-title":"Acute myocardial infarction during regadenoson myocardial perfusion imaging","volume":"33","author":"Shah","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1007\/s12350-014-9898-0_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12350-013-9694-2","article-title":"Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis","volume":"20","author":"Hsi","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-014-9898-0_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-540-89615-9_6","article-title":"Adenosine receptors and the heart: Role in regulation of coronary blood flow and cardiac electrophysiology","volume":"193","author":"Mustafa","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1007\/s12350-014-9898-0_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(03)00402-6","article-title":"Modification of cardiovascular response of posterior hypothalamic adenosine A(2) receptor stimulation by adenylate cylase, guanylate cyclase and by K(ATP) channel blockade in anesthetized rats","volume":"344","author":"Kang","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1007\/s12350-014-9898-0_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00259-013-2619-0","article-title":"Regadenoson in Europe: First-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy","volume":"41","author":"Brinkert","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-014-9898-0_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cardiores.2006.07.020","article-title":"Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release","volume":"72","author":"Hove-Madsen","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1007\/s12350-014-9898-0_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0022-3565(24)37687-6","article-title":"Immunological characterization of adenosine A2A receptors in human and porcine cardiovascular tissues","volume":"286","author":"Marala","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-014-9898-0_bib13","doi-asserted-by":"crossref","first-page":"H1035","DOI":"10.1152\/ajpheart.00808.2001","article-title":"Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: Role of receptor localization","volume":"282","author":"Kilpatrick","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1007\/s12350-014-9898-0_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(24)29370-8","article-title":"Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: Inverse relationship between affinity and duration of action of A2A agonists","volume":"298","author":"Gao","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-014-9898-0_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/eurheartj\/ehq464","article-title":"Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors","volume":"32","author":"Llach","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-014-9898-0_bib16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2165\/00003088-200645120-00005","article-title":"A population pharmacokinetic\/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers","volume":"45","author":"Gordi","year":"2006","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-014-9898-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-014-9898-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123073312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123073312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-014-9898-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:56:20Z","timestamp":1761026180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123073312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1071358123073312"],"URL":"https:\/\/doi.org\/10.1007\/s12350-014-9898-0","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asystole following regadenoson infusion in stable outpatients","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-014-9898-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}